T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric zaps to the gut could tame diabetes and fatty liver
Disease control Not yet recruitingThis study tests a procedure called pulsENDO that uses mild electric pulses to regenerate the lining of the duodenum (the first part of the small intestine). The goal is to improve blood sugar control and reduce fat buildup in the liver for people with type 2 diabetes and fatty l…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New diabetes combo pill aims to beat single drugs in major trial
Disease control Not yet recruitingThis study tests whether starting treatment with two experimental drugs together (DWP16001 and DWC202518) works better than either drug alone for people with type 2 diabetes. About 510 adults will take the combo or a single drug for 24 weeks, and researchers will measure changes …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE3 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to improve diabetes management
Disease control Not yet recruitingThis study looks at adding a drug called Chiglitazar to standard SGLT-2 inhibitor treatment for adults with type 2 diabetes whose blood sugar is not well controlled. Researchers will track changes in blood sugar, heart, kidney, and liver health over time. About 3550 participants …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New triple therapy aims to protect kidneys in diabetes patients
Disease control Not yet recruitingThis study tests whether adding a weekly injection called dulaglutide to two standard pills (SGLT-2 inhibitors and finerenone) can better protect the kidneys of Chinese adults with type 2 diabetes and mild-to-moderate chronic kidney disease. About 468 participants will be randoml…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New Triple-Drug diabetes pill aims for better blood sugar control
Disease control Not yet recruitingThis study tests a new once-daily tablet that combines three diabetes drugs (henagliflozin, retagliptin, and metformin) in Chinese adults with type 2 diabetes. About 300 participants will take the pill for 24 weeks to see how well it lowers blood sugar and check for side effects.…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New diabetes drug aims to slow kidney failure in High-Risk patients
Disease control Not yet recruitingThis study tests whether adding ganagliflozin tablets to standard care can slow kidney disease progression in 1,244 adults with type 2 diabetes and chronic kidney disease. Participants will take either ganagliflozin or a placebo daily for 120 weeks. The main goal is to measure ch…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE4 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo diabetes pill tested in healthy volunteers
Knowledge-focused Not yet recruitingThis study tests whether a new single pill that combines two diabetes drugs (chiglitazar and metformin) works the same as taking them separately. It involves 64 healthy adults who will take both versions and have their blood levels measured. The goal is to see if the combo pill i…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New diabetes pill put to the test: does food change how it works?
Knowledge-focused Not yet recruitingThis early-phase trial in 28 healthy Chinese adults tests a new fixed-dose combination pill for type 2 diabetes. One part checks whether a high-fat meal changes how much drug gets into the blood. The other part looks at drug levels after taking the pill daily for 10 days. The goa…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Could a single pill replace two for diabetes?
Knowledge-focused Not yet recruitingThis pilot study will test whether a new fixed-dose combination tablet containing Chiglitazar and Metformin works the same in the body as taking the two drugs separately. Twenty-four healthy adults will receive both versions under fed conditions, and researchers will measure drug…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: NA • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC